Latest News
-
Arrayjet secures $1 million bioprinter contract with world's largest protein microarray producer
- Posted: 15/07/20
Arrayjet secures $1million bioprinter contract with world's largest protein microarray producer: Contract secured with North American Proteomic R+D specialist CDI Laboratories based in Baltimore and Puerto Rico
-
Webinar: Proteome-wide analysis of serum antibodies in COVID-19 patients using SARS-CoV-2 proteome microarray
- Posted: 24/06/20
We will be hosting our second webinar of the year on Tuesday 28th July at 12.30pm. Prof. Xiaobo Yu from the National Centre for Protein Sciences in Beijing will be delivering a presentation on his latest research with the title “Proteome-wide analysis of serum antibodies in COVID-19 patients using SARS-CoV-2 proteome microarray”.
-
Arrayjet at cutting edge of Covid-19 antibody screening trials to aid quest for vaccine development
- Posted: 05/05/20
- Patient blood serum tests could reach 18000 per day using the ArrayPlex high-throughput biologics screening assay.
- R&D tests use synthetic COVID-19 proteins printed on “biological microchips” alongside entire the human proteome
- Collaborative partnership calls for diagnostic and life science companies with capabilities to implement their novel infectious sample screening technology to come forward
-
Webinar: High-density Protein Arrays and Affinity Proteomics
- Posted: 04/02/20
Arrayjet welcomes Ronald Sjöberg from the SciLifeLab to discuss the high-density protein array developed by Peter Nilsson's group